Imiquimod Cream
Product Images NDC 71335-3000

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 71335-3000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A flowchart diagram showing patient enrollment and treatment outcomes in a study of Imiquimod Cream versus Vehicle. It details the number of patients who completed 16 weeks of treatment, those who withdrew, and follow-up results regarding lesion clarity.*
FDA Label Image

Image 11 (Image 01)

Image 11 (Image 01)
Chemical structure of Imiquimod, showing its molecular arrangement with nitrogen and carbon atoms, including the characteristic fused ring system and side chain.*
FDA Label Image

Label (Lbl713353000)

Label (Lbl713353000)
Imiquimod Cream 5% topical single-use packets, containing 12.5 mg per 0.25 g. Package includes 24 single-use packets. Label shows the NDC 71335-3000-1 and indicates the product is relabeled by Bryant Ranch Prepack, Inc., with manufacturing by Padagis. The label lists inactive ingredients and storage instructions, and notes it is for dermatologic use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.